SK6993A3 - Oxime derivatives, process for their manufacture, pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors - Google Patents

Oxime derivatives, process for their manufacture, pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors Download PDF

Info

Publication number
SK6993A3
SK6993A3 SK6993A SK6993A SK6993A3 SK 6993 A3 SK6993 A3 SK 6993A3 SK 6993 A SK6993 A SK 6993A SK 6993 A SK6993 A SK 6993A SK 6993 A3 SK6993 A3 SK 6993A3
Authority
SK
Slovakia
Prior art keywords
group
carbon atoms
alkyl
methoxy
formula
Prior art date
Application number
SK6993A
Other languages
English (en)
Slovak (sk)
Inventor
Thomas G Bird
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of SK6993A3 publication Critical patent/SK6993A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK6993A 1992-02-07 1993-02-05 Oxime derivatives, process for their manufacture, pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors SK6993A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92400318 1992-02-07
EP92402764 1992-10-09

Publications (1)

Publication Number Publication Date
SK6993A3 true SK6993A3 (en) 1993-09-09

Family

ID=26132332

Family Applications (1)

Application Number Title Priority Date Filing Date
SK6993A SK6993A3 (en) 1992-02-07 1993-02-05 Oxime derivatives, process for their manufacture, pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors

Country Status (20)

Country Link
US (2) US5332757A (zh)
EP (1) EP0555068B1 (zh)
JP (1) JPH05286957A (zh)
AT (1) ATE136546T1 (zh)
AU (1) AU658964B2 (zh)
CA (1) CA2088864A1 (zh)
CZ (1) CZ13393A3 (zh)
DE (1) DE69302109T2 (zh)
ES (1) ES2086878T3 (zh)
FI (1) FI930475A (zh)
GB (1) GB9300894D0 (zh)
GR (1) GR3019634T3 (zh)
HU (1) HUT63840A (zh)
IL (1) IL104624A0 (zh)
NO (1) NO930411L (zh)
NZ (1) NZ245772A (zh)
PL (1) PL297666A1 (zh)
SK (1) SK6993A3 (zh)
TW (1) TW224094B (zh)
ZW (1) ZW1293A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108187A0 (en) * 1993-01-28 1994-04-12 Zenecca Limited Oxime derivatives
ZA945250B (en) * 1993-07-27 1995-01-27 Zeneca Ltd Thiazole derivatives
WO1995030668A1 (en) * 1994-05-06 1995-11-16 Zeneca Limited Cyclic ether derivatives and pharmaceutical composition containing them
US5668159A (en) * 1996-05-08 1997-09-16 The Dupont Merck Pharmaceutical Company 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as IIb/IIIa antagonists
KR20000067915A (ko) 1996-07-19 2000-11-25 센토르 파마슈티칼스, 인크. 푸란 니트론 화합물
ATE228123T1 (de) * 1998-01-16 2002-12-15 Centaur Pharmaceuticals Inc Thiophennitronderivate
CN1291980A (zh) * 1998-01-16 2001-04-18 桑道药品有限公司 硫醚呋喃硝酮化合物
WO2004108720A1 (en) * 2003-06-11 2004-12-16 Merck Frosst Canada Ltd. 7- (1, 3-thiazol-2-yl)thio!-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
WO2009069044A1 (en) * 2007-11-26 2009-06-04 Pfizer Inc. Pyrazole derivatives as 5-lo inhibitors
CN104447658A (zh) * 2014-12-04 2015-03-25 杭州杜易科技有限公司 一种卤代4-色满酮衍生物的制备方法
EP3601267A1 (en) 2017-03-21 2020-02-05 Bayer Pharma Aktiengesellschaft 2-methyl-quinazolines
WO2019201848A1 (en) 2018-04-18 2019-10-24 Bayer Pharma Aktiengesellschaft 2-methyl-aza-quinazolines
BR112021008900A2 (pt) * 2018-11-08 2021-08-10 Unilever Ip Holdings B.V. processo para a síntese de lactama
EP3880758B1 (en) * 2018-11-08 2024-06-26 Unilever Global Ip Limited Method of treatment of a surface
JPWO2020250880A1 (zh) * 2019-06-11 2020-12-17

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
US4567184A (en) * 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4876346A (en) * 1985-05-02 1989-10-24 American Home Products Corporation Quinoline compounds
DE3617183A1 (de) * 1985-11-16 1987-05-27 Bayer Ag Substituierte benzylether
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
US4868193A (en) * 1986-09-24 1989-09-19 Rorer Pharmaceutical Corporation Styryl tetrazoles and anti-allergic use thereof
GB8927287D0 (en) * 1988-12-23 1990-01-31 Ici Plc Cyclic ether derivatives
IL92620A0 (en) * 1988-12-23 1990-08-31 Ici Pharma Cycloalkane derivatives
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
IL93344A0 (en) * 1989-02-28 1990-11-29 Ici Plc Heterocyclic cyclic ethers
US5134148A (en) * 1989-02-28 1992-07-28 Imperial Chemical Industries Plc Heterocycles for use as inhibitors of leukotrienes
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
IE902113A1 (en) * 1989-07-18 1991-06-19 Ici Plc Diaryl ether cyclic ethers
IE64358B1 (en) * 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles
ES2083526T3 (es) * 1990-06-21 1996-04-16 Zeneca Ltd Derivados piranicos biciclicos y su uso como inhibidores de 5-lipoxigenasa.
IE911853A1 (en) * 1990-06-21 1992-01-01 Ici Plc Heterocyclene derivatives
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives

Also Published As

Publication number Publication date
US5482966A (en) 1996-01-09
EP0555068A1 (en) 1993-08-11
AU3197293A (en) 1993-08-12
FI930475A (fi) 1993-08-08
HU9300272D0 (en) 1993-04-28
AU658964B2 (en) 1995-05-04
NZ245772A (en) 1995-05-26
NO930411D0 (no) 1993-02-05
PL297666A1 (en) 1993-10-18
IL104624A0 (en) 1993-06-10
DE69302109D1 (de) 1996-05-15
JPH05286957A (ja) 1993-11-02
HUT63840A (en) 1993-10-28
CZ13393A3 (en) 1993-10-13
TW224094B (zh) 1994-05-21
ATE136546T1 (de) 1996-04-15
NO930411L (no) 1993-08-09
US5332757A (en) 1994-07-26
ES2086878T3 (es) 1996-07-01
GB9300894D0 (en) 1993-03-10
EP0555068B1 (en) 1996-04-10
GR3019634T3 (en) 1996-07-31
ZW1293A1 (en) 1993-09-29
FI930475A0 (fi) 1993-02-03
CA2088864A1 (en) 1993-08-08
DE69302109T2 (de) 1996-10-17

Similar Documents

Publication Publication Date Title
SK6993A3 (en) Oxime derivatives, process for their manufacture, pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors
US5276037A (en) Heterocyclic 5-lipoxygenase inhibitors
CA2377803C (en) Phenyl sulfamate derivatives
SK5542001A3 (en) Prostaglandin endoperoxide h synthase biosynthesis inhibitors
JP2005533858A (ja) 化合物
HUT77517A (hu) Biciklusos tetrahidro-pirazolo-piridin-származékok, alkalmazásuk és ilyen vegyületeket tartalmazó gyógyászati készítmények
JPH03135936A (ja) アルコールおよびエーテル誘導体、その製法並びに該誘導体含有する５‐リポキシゲナーゼ阻害製薬学的組成物
EP0532239B1 (en) Benzenesulphonamide derivatives as 5-lipoxygenase inhibitors
US5236948A (en) Sulphonamide derivatives
EP0623614A1 (en) 4-Aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors
US5334614A (en) Hydroxylamine derivatives
US5457125A (en) Oxime derivatives
EP0570197B1 (en) Hydroxylamine derivatives
US5258399A (en) Sulphonamide derivatives
EP0681576A1 (en) Oxime derivatives
EP0570196B1 (en) Oxime derivatives
US5453439A (en) Hydroxylamine derivatives
JPS5988458A (ja) アミン誘導体およびその塩
US5478843A (en) Thiazole derivatives
EP0610032A1 (en) Acetanilide derivatives
EP0636624A1 (en) Thiazole derivatives as lipoxygenase inhibitors
WO1995004055A1 (en) Thiazole derivatives as lipoxygenase inhibitors
CA2113913A1 (en) Acetanilide derivatives